
20n YC Başvurusu
20n, Healthcare şirketi olarak Winter 2015 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.
- YC grubu
- Winter 2015
- Sektör
- HealthcareIndustrial Bio
- Ekip büyüklüğü
- 2
- Durum
- Inactive
- Lansmanı Yapıldı
- 2014
Kurucular
Saurabh SrivastavaFounder/CEO
Chris AndersonFounder/CSO
20n ne yapar
The next decade is going to see a biotech revolution fueled by three technologies: ability to read DNA (sequencing), ability to write DNA (synthesis), and computational systems that predict what DNA to read and write. With sequencing and synthesis being mainstream now [1], 20n provides the computational systems that predict DNA design for novel industrial biotech and health applications. At 20n, we are taking a fresh look at turning biological data into information. We approach it as a big data learning problem, and bring to bear techniques from machine learning, distributed systems, AI planning, program synthesis, data mining, and natural language processing. With the support of DARPA [2], we are building a team of computer scientists, and bioengineers to look at biology in fundamentally new ways. Our current customers include industrial biotech firms that are leading the charge in transitioning us from traditional unsustainable means of manufacturing to sustainable biological processes leading to advanced fuels, materials, therapeutics, and flavors and fragrances. 20n’s technology helps them enter markets previously thought inaccessible for biology. [1] Sequencing DNA costs $4k/genome ( and is expected to go down to $1k/genome. Synthesizing DNA is at 20cents/bp, and is expected to go down to 0.1cents/bp. [2] DARPA in the past supported work that led to the internet, stealth planes, GPS, and even Douglas Engelbart’s mother-of-all-demos.
20n'in YC başvurusu, yeniden yapılandırılmış
Y Combinator başvurusu
20n, Winter 2015 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
20n
Using AI to predict biochemistry for manufacturing
We are building computational systems that use AI and machine learning to predict DNA designs for industrial biotech and therapeutics. Our product helps industrial biotech firms design biological systems that can produce fuels, materials, flavors, and medicines that were previously inaccessible by traditional methods.
We live in San Francisco, CA, and would base the company here after YC.
San Francisco has the technical talent and biotech ecosystem we need to grow. It keeps us close to early industrial biotech customers and partners.
Tam başvuruda 21 ek cevap
Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.
Sıkça Sorulan Sorular
Bu, 20n şirketinin gerçek YC başvurusu mu?
Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, 20n'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. 20n gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.
20n hangi YC grubundaydı?
20n, Y Combinator Winter 2015 grubundaydı.
20n kim tarafından kuruldu?
20n, Saurabh Srivastava, Chris Anderson tarafından kuruldu.
20n ne iş yapar?
Using AI to predict biochemistry for manufacturing and therapeutics
Tam yeniden oluşturulmuş başvuruyu nasıl okurum?
Ücretsiz bir Round Funded hesabı oluşturun. 20n'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.